Point72 Asset Management’s Cyclacel Pharmaceuticals CYCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64
| Closed | -$4.28K | – | 1422 |
|
|
2025
Q1 | $4.28K | Hold |
64
| – | – | ﹤0.01% | 1214 |
|
|
2024
Q4 | $5.77K | Hold |
64
| – | – | ﹤0.01% | 1230 |
|
|
2024
Q3 | $15.2K | Hold |
64
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q2 | $24.8K | Hold |
64
| – | – | ﹤0.01% | 1130 |
|
|
2024
Q1 | $32.4K | Hold |
64
| – | – | ﹤0.01% | 1363 |
|
|
2023
Q4 | $40.9K | Hold |
64
| – | – | ﹤0.01% | 1286 |
|
|
2023
Q3 | $81.6K | Hold |
64
| – | – | ﹤0.01% | 1348 |
|
|
2023
Q2 | $135K | Hold |
64
| – | – | ﹤0.01% | 996 |
|
|
2023
Q1 | $131K | Hold |
64
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q4 | $153K | Hold |
64
| – | – | ﹤0.01% | 912 |
|
|
2022
Q3 | $336K | Hold |
64
| – | – | ﹤0.01% | 916 |
|
|
2022
Q2 | $248K | Hold |
64
| – | – | ﹤0.01% | 937 |
|
|
2022
Q1 | $702K | Hold |
64
| – | – | ﹤0.01% | 907 |
|
|
2021
Q4 | $895K | Hold |
64
| – | – | ﹤0.01% | 867 |
|
|
2021
Q3 | $1.21M | Hold |
64
| – | – | 0.01% | 780 |
|
|
2021
Q2 | $1.36M | Hold |
64
| – | – | 0.01% | 716 |
|
|
2021
Q1 | $1.64M | Buy |
+64
| New | +$1.64M | 0.01% | 705 |
|